Healthcare Triangle, Inc.
HCTIHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHealthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the. The $251K market capitalization puts HCTI squarely in micro-cap range for its industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.
Market Cap
$251,194
Beta
1.09
P/E (TTM)
—
P/E (Fwd)
-0.43
EPS (TTM)
$-1009.38
EPS (Fwd)
$-0.78
ROE
-57.4%
ROA
-20.9%
Cash
$2.0M
Total Debt
$13.0M
Free CF
-$6.4M
52W Change
-99.8%
Annual Financials
Cash vs Debt
Where HCTI stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, HCTI finished 78.95% below its 150-day moving average ($1.71) and 92.56% below its 200-day moving average ($4.84). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HCTI overbought or oversold?
At the October 20, 2026 close, HCTI's RSI(14) was 22.5, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $2.0M in cash, though total debt stands at $13.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$6.4M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -57.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $45.9M (2022) to $13.9M (2025), a 70% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Healthcare Triangle, Inc.'s trajectory.